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Suppressor of cytokine signaling-1 (SOCS-1) is an induc-
ible negative regulator of the JAK/STAT signal pathway;
SOCS-1 is expressed in dendritic cells (DCs) and nega-
tively regulates activation and type 1 regulatory cytokine
production. Infection with human immunodeficiency
virus type 1 (HIV-1) results in cytokine dysregulation by
DCs. Since effector/memory formation depends upon
clonal expansion of naïve T cells following the initial
encounter with antigen and since cytokines play a critical
role in the initiation and regulation of immune responses
by DCs, events that negatively affect antigen presentation,
co-stimulation and cytokine production by DCs can also
negatively affect T cell immune responses. We have earlier
reported that HIV-1 transgenic rats have defects in type 1
cytokine production, type 1 cytokine responses and gener-
ation of effector/memory CD4 T cell subsets. Here we
show that BMDC from HIV-1 transgenic rats express sig-
nificantly elevated levels of IL10 and reduced levels of IL-
12 proteins in addition to elevated SOCS-1 mRNA follow-
ing stimulation with lipolysaccharide (LPS) compared to
age matched controls. These results suggest that elevated
levels of SOCS-1 in DCs may negatively regulate type 1
cytokine production leading to dysregulation of T helper
1 responses reported in the HIV-1 transgenic rat.
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